BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22486562)

  • 1. Oxidative stress modulates KLF6Full and its splice variants.
    Urtasun R; Cubero FJ; Nieto N
    Alcohol Clin Exp Res; 2012 Nov; 36(11):1851-62. PubMed ID: 22486562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions.
    Hanoun N; Bureau C; Diab T; Gayet O; Dusetti N; Selves J; Vinel JP; Buscail L; Cordelier P; Torrisani J
    J Hepatol; 2010 Nov; 53(5):880-8. PubMed ID: 20801538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of KLF6 and its splice variant KLF6V on proliferation and differentiation of human hepatocellular carcinoma HepG2 cells].
    Pan XC; Chen Z; Ji F; Guo ZS; Chen M; Fu JJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):683-7. PubMed ID: 18822210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
    Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
    RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
    Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
    Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction.
    Botella LM; Sanz-Rodriguez F; Komi Y; Fernandez-L A; Varela E; Garrido-Martin EM; Narla G; Friedman SL; Kojima S
    Biochem J; 2009 Apr; 419(2):485-95. PubMed ID: 19076057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease.
    Bechmann LP; Gastaldelli A; Vetter D; Patman GL; Pascoe L; Hannivoort RA; Lee UE; Fiel I; Muñoz U; Ciociaro D; Lee YM; Buzzigoli E; Miele L; Hui KY; Bugianesi E; Burt AD; Day CP; Mari A; Agius L; Walker M; Friedman SL; Reeves HL
    Hepatology; 2012 Apr; 55(4):1083-93. PubMed ID: 22095588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
    Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
    Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury.
    Ghiassi-Nejad Z; Hernandez-Gea V; Woodrell C; Lang UE; Dumic K; Kwong A; Friedman SL
    Hepatology; 2013 Feb; 57(2):786-96. PubMed ID: 22961688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species.
    Nieto N; Friedman SL; Cederbaum AI
    Hepatology; 2002 Jan; 35(1):62-73. PubMed ID: 11786960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of cytochrome P450 2E1 induces heme oxygenase-1 through ERK MAPK pathway.
    Gong P; Cederbaum AI; Nieto N
    J Biol Chem; 2003 Aug; 278(32):29693-700. PubMed ID: 12777398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.
    Vetter D; Cohen-Naftaly M; Villanueva A; Lee YA; Kocabayoglu P; Hannivoort R; Narla G; M Llovet J; Thung SN; Friedman SL
    Hepatology; 2012 Oct; 56(4):1361-70. PubMed ID: 22535637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor function.
    Rodríguez E; Aburjania N; Priedigkeit NM; DiFeo A; Martignetti JA
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol metabolism by alcohol dehydrogenase or cytochrome P
    Doody EE; Groebner JL; Walker JR; Frizol BM; Tuma DJ; Fernandez DJ; Tuma PL
    Am J Physiol Gastrointest Liver Physiol; 2017 Dec; 313(6):G558-G569. PubMed ID: 28864499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
    Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
    Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron and CYP2E1-dependent oxidative stress and toxicity.
    Cederbaum AI
    Alcohol; 2003 Jun; 30(2):115-20. PubMed ID: 12957295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling.
    Schattenberg JM; Wang Y; Rigoli RM; Koop DR; Czaja MJ
    Hepatology; 2004 Feb; 39(2):444-55. PubMed ID: 14767997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines.
    Cheng XF; Li D; Zhuang M; Chen ZY; Lu DX; Hattori T
    Tohoku J Exp Med; 2008 Sep; 216(1):35-45. PubMed ID: 18719336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells.
    Gehrau RC; D'Astolfo DS; Andreoli V; Bocco JL; Koritschoner NP
    Mutat Res; 2011 Feb; 707(1-2):15-23. PubMed ID: 21147133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.